Alan Shaw - Publications

Affiliations: 
2011-2017 Medical Biochemistry and Biophysics Karolinska Institute, Stockholm, Sweden 
 2017- University of California, Berkeley, Berkeley, CA 
Area:
DNA origami, ephrin signaling, antibody binding, optical tweezers, nanopore sequencing
Website:
bustamante.berkeley.edu/current-lab-members/

5/67 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Shaw A, Hoffecker IT, Smyrlaki I, Rosa J, Grevys A, Bratlie D, Sandlie I, Michaelsen TE, Andersen JT, Högberg B. Publisher Correction: Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies. Nature Nanotechnology. PMID 30783200 DOI: 10.1038/s41565-019-0404-3  1
2019 Shaw A, Hoffecker IT, Smyrlaki I, Rosa J, Grevys A, Bratlie D, Sandlie I, Michaelsen TE, Andersen JT, Högberg B. Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies. Nature Nanotechnology. PMID 30643273 DOI: 10.1038/s41565-018-0336-3  1
2015 Shaw A, Benson E, Högberg B. Purification of functionalized DNA origami nanostructures. Acs Nano. 9: 4968-75. PMID 25965916 DOI: 10.1021/nn507035g  1
2014 Shaw A, Lundin V, Petrova E, Förd?s F, Benson E, Al-Amin A, Herland A, Blokzijl A, Högberg B, Teixeira AI. Spatial control of membrane receptor function using ligand nanocalipers. Nature Methods. 11: 841-6. PMID 24997862 DOI: 10.1038/nmeth.3025  1
2012 Zhao YX, Shaw A, Zeng X, Benson E, Nyström AM, Högberg B. DNA origami delivery system for cancer therapy with tunable release properties. Acs Nano. 6: 8684-91. PMID 22950811 DOI: 10.1021/nn3022662  1
Low-probability matches
2020 Chen Z, Shaw A, Wilson H, Woringer M, Darzacq X, Marqusee S, Wang Q, Bustamante C. Single-molecule diffusometry reveals no catalysis-induced diffusion enhancement of alkaline phosphatase as proposed by FCS experiments. Proceedings of the National Academy of Sciences of the United States of America. PMID 32817484 DOI: 10.1073/pnas.2006900117  0.04
2013 Shaw AR. Human papillomavirus vaccines six years after approval. Annual Review of Medicine. 64: 91-100. PMID 23190152 DOI: 10.1146/annurev-med-061511-125226  0.04
2013 Shaw AR. The rotavirus saga revisited. Annual Review of Medicine. 64: 165-74. PMID 23121179 DOI: 10.1146/annurev-med-121511-093810  0.04
2012 Shaw AR. Universal influenza vaccine: the holy grail? Expert Review of Vaccines. 11: 923-7. PMID 23002973 DOI: 10.1586/erv.12.73  0.04
2012 Taylor DN, Treanor JJ, Sheldon EA, Johnson C, Umlauf S, Song L, Kavita U, Liu G, Tussey L, Ozer K, Hofstaetter T, Shaw A. Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response. Vaccine. 30: 5761-9. PMID 22796139 DOI: 10.1016/j.vaccine.2012.06.086  0.04
2011 Liu G, Tarbet B, Song L, Reiserova L, Weaver B, Chen Y, Li H, Hou F, Liu X, Parent J, Umlauf S, Shaw A, Tussey L. Immunogenicity and efficacy of flagellin-fused vaccine candidates targeting 2009 pandemic H1N1 influenza in mice. Plos One. 6: e20928. PMID 21687743 DOI: 10.1371/journal.pone.0020928  0.04
2011 Turley CB, Rupp RE, Johnson C, Taylor DN, Wolfson J, Tussey L, Kavita U, Stanberry L, Shaw A. Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine. 29: 5145-52. PMID 21624416 DOI: 10.1016/j.vaccine.2011.05.041  0.04
2011 Taylor DN, Treanor JJ, Strout C, Johnson C, Fitzgerald T, Kavita U, Ozer K, Tussey L, Shaw A. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI). Vaccine. 29: 4897-902. PMID 21596084 DOI: 10.1016/j.vaccine.2011.05.001  0.04
2010 Talbot HK, Rock MT, Johnson C, Tussey L, Kavita U, Shanker A, Shaw AR, Taylor DN. Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin. Plos One. 5: e14442. PMID 21203437 DOI: 10.1371/journal.pone.0014442  0.04
2010 Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I, Shaw A. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine. 28: 8268-74. PMID 20969925 DOI: 10.1016/j.vaccine.2010.10.009  0.04
2009 Harbecke R, Oxman MN, Arnold BA, Ip C, Johnson GR, Levin MJ, Gelb LD, Schmader KE, Straus SE, Wang H, Wright PF, Pachucki CT, Gershon AA, Arbeit RD, Davis LE, ... ... Shaw A, et al. A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. Journal of Medical Virology. 81: 1310-22. PMID 19475609 DOI: 10.1002/jmv.21506  0.04
2006 Wu Y, Przysiecki C, Flanagan E, Bello-Irizarry SN, Ionescu R, Muratova O, Dobrescu G, Lambert L, Keister D, Rippeon Y, Long CA, Shi L, Caulfield M, Shaw A, Saul A, et al. Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex. Proceedings of the National Academy of Sciences of the United States of America. 103: 18243-8. PMID 17110440 DOI: 10.1073/pnas.0608545103  0.04
2006 Shaw AR. The rotavirus vaccine saga. Annual Review of Medicine. 57: 167-80. PMID 16409143 DOI: 10.1146/annurev.med.57.121304.131359  0.04
2005 DiStefano DJ, Kraiouchkine N, Mallette L, Maliga M, Kulnis G, Keller PM, Clark HF, Shaw AR. Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. Journal of Clinical Microbiology. 43: 5876-80. PMID 16333070 DOI: 10.1128/JCM.43.12.5876-5880.2005  0.04
2005 Shaw AR. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented? Gynecologic Oncology. 99: S246-8. PMID 16213009 DOI: 10.1016/j.ygyno.2005.07.097  0.04
2005 Myers R, Greiner S, Harvey M, Soeffker D, Frenzke M, Abraham K, Shaw A, Rozenblatt S, Federspiel MJ, Russell SJ, Peng KW. Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer. Cancer Gene Therapy. 12: 593-9. PMID 15746945 DOI: 10.1038/sj.cgt.7700823  0.04
2004 Clark HF, Lawley D, Shrager D, Jean-Guillaume D, Offit PA, Whang SY, Eiden JJ, Bennett PS, Kaplan KM, Shaw AR. Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4. The Pediatric Infectious Disease Journal. 23: 206-11. PMID 15014293 DOI: 10.1097/01.inf.0000115503.55212.bf  0.04
2004 Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer. Annual Review of Medicine. 55: 319-31. PMID 14746524 DOI: 10.1146/annurev.med.55.091902.103520  0.04
2003 Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. The Journal of Infectious Diseases. 188: 1336-44. PMID 14593591 DOI: 10.1086/379048  0.04
2003 Szymkowiak C, Kwan WS, Su Q, Toner TJ, Shaw AR, Youil R. Rapid method for the characterization of 3' and 5' UTRs of influenza viruses. Journal of Virological Methods. 107: 15-20. PMID 12445933 DOI: 10.1016/S0166-0934(02)00184-2  0.04
2002 Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY, Lin TY, Lee BW, Kwan K, Kasim SM, Chan CY, Kaplan KM, Distefano DJ, Harmon AL, Golie A, ... ... Shaw A, et al. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine. 20: 2942-9. PMID 12126906 DOI: 10.1016/S0264-410X(02)00245-1  0.04
2018 Martin D, Lykoudis PM, Jones G, Highton D, Shaw A, James S, Wei Q, Fusai G. Impact of postoperative intravenous fluid administration on complications following elective hepato-pancreato-biliary surgery. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. PMID 30243876 DOI: 10.1016/j.hbpd.2018.09.001  0.01
2018 Shaw A. Using the Social Return on Investment Framework to Evaluate Behavior Changes of Individuals Living With Learning Difficulties Social Marketing Quarterly. 24: 281-298. DOI: 10.1177/1524500418810713  0.01
2017 Shaw A. Leading voluntary-aided faith schools in England: perspectives from Catholic, Anglican and Jewish headteachers International Studies in Catholic Education. 9: 89-107. DOI: 10.1080/19422539.2017.1286913  0.01
2016 Pol E, Roos H, Markey F, Elwinger F, Shaw A, Karlsson R. Evaluation of Calibration-Free Concentration Analysis provided by Biacore™ systems. Analytical Biochemistry. PMID 27402174 DOI: 10.1016/j.ab.2016.07.009  0.01
2015 Magraw CB, Garaas R, Shaw A, Phillips C, Turvey TA. Changes in scleral exposure following modified Le Fort III osteotomy. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 120: 119-24.e1. PMID 26166028 DOI: 10.1016/j.oooo.2015.04.005  0.01
2013 Carapau D, Mitchell R, Nacer A, Shaw A, Othoro C, Frevert U, Nardin E. Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin. Infection and Immunity. 81: 4350-62. PMID 24042110 DOI: 10.1128/IAI.00263-13  0.01
2012 Shaw A, Leavell S, Wimmer P, Bartholomeus A, Furniss S, Haney C, Condit G, Milburn B, Doshier M, Zuckerman N, Beck TM, Zuckerman DS. Patient-reported outcomes on integrative therapies for pain, tension, and level of comfort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 58. PMID 28146971 DOI: 10.1200/jco.2012.30.34_suppl.58  0.01
2012 Shaw A. New technologies for new influenza vaccines. Vaccine. 30: 4927-33. PMID 22579861 DOI: 10.1016/j.vaccine.2012.04.095  0.01
2011 Kanesa-thasan N, Shaw A, Stoddard JJ, Vernon TM. Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies. Pediatrics. 127: S16-22. PMID 21502248 DOI: 10.1542/peds.2010-1722D  0.01
2011 Shaw A. Market segmentation and the impact of online media Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 11: 254-262. DOI: 10.1177/1745790411416542  0.01
2006 Inglis S, Shaw A, Koenig S. Chapter 11: HPV vaccines: commercial research & development. Vaccine. 24: S3/99-105. PMID 16950023 DOI: 10.1016/j.vaccine.2006.05.119  0.01
2006 Kulik A, Dubnova-Erlikh S, Shaw A. Bread and Matzoth The Slavic and East European Journal. 50: 710. DOI: 10.2307/20459382  0.01
2005 Chen M, Tao Y, Lim J, Shaw A, Chory J. Regulation of phytochrome B nuclear localization through light-dependent unmasking of nuclear-localization signals. Current Biology : Cb. 15: 637-42. PMID 15823535 DOI: 10.1016/j.cub.2005.02.028  0.01
2005 Zerboni L, Hinchliffe S, Sommer MH, Ito H, Besser J, Stamatis S, Cheng J, Distefano D, Kraiouchkine N, Shaw A, Arvin AM. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology. 332: 337-46. PMID 15661165 DOI: 10.1016/j.virol.2004.10.047  0.01
2005 Yefimov I, Shaw A. One Step out of Line: Joseph Brodsky in Leningrad, 1965 World Literature Today. 79: 41. DOI: 10.2307/40158934  0.01
2004 Roycroft B, Akhter M, Maaskant P, Corbett B, Shaw A, Bradley L, de Mierry P, Poisson MA. Origin of power fluctuations in GaN resonant-cavity light-emitting diodes. Optics Express. 12: 736-41. PMID 19474879  0.01
2004 Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, et al. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants. Virus Research. 105: 183-94. PMID 15351492 DOI: 10.1016/j.virusres.2004.05.009  0.01
2004 Ward RL, Bernstein DI, Smith VE, Sander DS, Shaw A, Eiden JJ, Heaton P, Offit PA, Clark HF. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine. The Journal of Infectious Diseases. 189: 2290-3. PMID 15181577 DOI: 10.1086/421248  0.01
2004 Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. The Journal of Pediatrics. 144: 184-90. PMID 14760258 DOI: 10.1016/j.jpeds.2003.10.054  0.01
2004 Lau Y, Kaplan K, Shaw A, Schödel F. Response to Letter to the Editor by Rentier and Gershon Vaccine. 22: 3227. DOI: 10.1016/J.VACCINE.2004.03.019  0.01
2004 Kiseleva I, Su Q, Toner T, Szymkowiak C, Kwan W, Kraiouchkine N, Rudenko L, Shaw A, Youil R. Development and evaluation of live influenza (LIV) cold-adapted reassortant vaccines in cell culture International Congress Series. 1263: 551-554. DOI: 10.1016/J.ICS.2004.02.158  0.01
2004 Kiseleva I, Klimov A, Su Q, Szymkowiak C, Toner T, Kwan W, Rudenko L, Shaw A, Youil R. Role of individual genes of the A/Leningrad/134/17/57 (H2N2) cold-adapted donor strain in manifestation of the temperature-sensitive phenotype of reassortant influenza A viruses International Congress Series. 1263: 547-550. DOI: 10.1016/J.ICS.2004.02.156  0.01
2004 Smith D, Martin C, Kassebom M, Petersen H, Shaw A, Skidmore B, Smith D, Stokes H, Willig A. A mission to preserve the geostationary region Advances in Space Research. 34: 1214-1218. DOI: 10.1016/J.ASR.2003.02.042  0.01
2002 Shaw A. The effectiveness of NHS cervical screening. Nursing Times. 98: 32-4. PMID 12168468  0.01
2002 Shaw A. Lessons in empowerment. Nursing Times. 98: 36-7. PMID 12168211  0.01
2001 Shaw A. Health on the Internet Journal of the Royal Society For the Promotion of Health. 121: 145. PMID 11688298 DOI: 10.1177/146642400112100308  0.01
1997 Halang W, Pereira C, de la Puente J, Shaw A, Skubich J, Tempelmeier T, van Katwijk J, Wedde H, Zalewski J. Real-Time Computing Education: Responding to a Challenge of the Next Century Ifac Proceedings Volumes. 30: 121-125. DOI: 10.1016/S1474-6670(17)41403-0  0.01
1997 Shaw A. Time-Stamped Event Histories: A Real-Time Programming Object 1 Ifac Proceedings Volumes. 30: 77-80. DOI: 10.1016/S1474-6670(17)41395-4  0.01
1996 Bender W, Chesnais P, Elo S, Shaw A, Shaw M. Enriching communities: Harbingers of news in the future Ibm Systems Journal. 35: 369-380. DOI: 10.1147/sj.353.0369  0.01
1991 Shaw A. OTA report: Introduction Terrorism. 14: 111-112. DOI: 10.1080/10576109108435863  0.01
1989 Schwartz EL, Shaw A, Wolfson E. A Numerical Solution to the Generalized Mapmaker's Problem: Flattening Nonconvex Polyhedral Surfaces Ieee Transactions On Pattern Analysis and Machine Intelligence. 11: 1005-1008. DOI: 10.1109/34.35506  0.01
1988 Shaw A. Special section on Operating Systems Communications of the Acm. 31: 255-257. DOI: 10.1145/42392.42395  0.01
1988 Schwartz EL, Merker B, Wolfson E, Shaw A. Applications of Computer Graphics and Image Processing to 2D and 3D Modeling of the Functional Architecture of Visual Cortex Ieee Computer Graphics and Applications. 8: 13-23. DOI: 10.1109/38.7745  0.01
1987 Shaw A. Phaedra in Tact The Hudson Review. 40: 225. DOI: 10.2307/3851096  0.01
1983 Shaw A. Microprocessors and Microcomputers. Hardware and Software Software & Microsystems. 2: 54. DOI: 10.1049/sm.1983.0017  0.01
1982 Furuta R, Scofield J, Shaw A. Document Formatting Systems: Survey, Concepts, and Issues Acm Computing Surveys. 14: 417-472. DOI: 10.1145/356887.356891  0.01
1981 McGhan M, Shaw A, Megill LR, Sedlacek W, Guthals PR, Fowler MM. Measurements of nitric oxide after a nuclear burst Journal of Geophysical Research. 86: 1167. DOI: 10.1029/JC086iC02p01167  0.01
1979 Shaw A. New Complexities In Operating Systems* Infor: Information Systems and Operational Research. 17: 87-96. DOI: 10.1080/03155986.1979.11731721  0.01
1976 Golde H, Shaw A. Why a separate computer facility for computer science education? Experiences at the UW computer sciences teaching laboratory Acm Sigcse Bulletin. 8: 11-20. DOI: 10.1145/382220.382221  0.01
1975 Shaw A. Image and Symbol in John 21 The Expository Times. 86: 311. DOI: 10.1177/001452467508601012  0.01
1975 Gillespie R, Shaw A. Computers and society Acm Sigcas Computers and Society. 6: 7-8. DOI: 10.1145/958660.958662  0.01
Hide low-probability matches.